Breath Testing Technology Will Feature at UEG Week
The upcoming congress in Barcelona will showcase noninvasive tools designed to help clinicians evaluate digestive disorders.
Updated on Sept. 23, 2026 in Asthma
Live Poll
Do you believe new non-invasive diagnostic technologies significantly improve patient care in your community?
Bedfont Scientific will demonstrate its Gastrolyzer breath testing devices at the upcoming United European Gastroenterology (UEG) Week in Barcelona from October 17th to 20th, 2026. The event aims to increase awareness of noninvasive diagnostic technologies for the global digestive health community.
Why it matters
Functional gastrointestinal disorders affect approximately 40% of people worldwide, highlighting the need for efficient diagnostic tools. Noninvasive breath testing offers a practical approach for clinicians to assess these conditions without more invasive procedures.
Bedfont Scientific reports 35 years of experience with its Gastrolyzer range of breath testing devices, which analyze gas concentrations in breath samples. This technology is designed to detect indicators of gastrointestinal issues, though clinical efficacy depends on standardized testing protocols.
The players
Bedfont Scientific
A medical device manufacturer with 50 years of experience, specializing in noninvasive breath analysis technologies.
Dr. Jafar Jafari
A clinical expert who will present his professional research and findings at the upcoming congress.
The details
The Gastrolyzer range uses specialized sensors to measure levels of hydrogen and methane gases in a patient's breath, which can be markers for underlying digestive health issues. By evaluating these gas profiles, clinicians can gain insights into gut function. Bedfont Scientific will provide live demonstrations of its portable Gastro+ and desktop GastroCH4ECK units to illustrate how these systems function in a clinical setting.
Timeline
UEG Week will occur from October 17th to 20th, 2026.
Live demonstrations at stand 29 run from October 18th to 20th, 2026.
Health Landscape
The integration of breath testing represents a shift toward noninvasive diagnostics within the international digestive health community. This development follows the broader trend established by United European Gastroenterology Week, which has served as a primary venue for evaluating new clinical technologies since 1992.
If you experience chronic gastrointestinal symptoms, this technology serves as a reminder to ask your physician about the diagnostic options available for your specific condition. Discussion with your doctor can determine if noninvasive testing is appropriate for your personal health assessment.
The takeaway
Noninvasive breath analysis is an evolving tool for managing common gastrointestinal complaints that impact a large portion of the population. Patients should track their specific symptom patterns and consult a gastroenterologist to determine which diagnostic tools are appropriate for their care.
Further reading
For broader context on diagnostic approaches in respiratory and related conditions, visit Asthma.
Source note: This article includes information reported by News-Medical.
Live Poll
Do you believe new non-invasive diagnostic technologies significantly improve patient care in your community?
